Interpace Diagnostics (NASDAQ: IDXG) reported Q1 EPS of $0.42, versus ($2.26) reported last year. Revenue for the quarter came in at $3.5 million, versus $3.04 million reported last year.

For earnings history and earnings-related data on Interpace Diagnostics (IDXG) click here.